meso-6k_20170502.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 Form 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

For the month of May 2017

Commission File Number 001-37626

Mesoblast Limited

(Exact name of Registrant as specified in its charter)

Not Applicable

(Translation of Registrant’s name into English)

Australia
(
Jurisdiction of incorporation or organization)

 

Silviu Itescu

Chief Executive Officer and Executive Director

Level 38

55 Collins Street

Melbourne 3000

Australia

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

Form 20-F Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes No

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes No

 


INFORMATION CONTAINED ON THIS REPORT ON FORM 6-K

On May 02, 2017, Mesoblast Limited submitted a Change in Director’s Interest Notice form to the Australian Securities Exchange, a copy of which is attached to this report as Exhibit 99.1.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized.

 

 

 

 

 

 

 

 

Mesoblast Limited

 

 

 

 

 

 

/s/ Charlie Harrison

 

 

 

 

 

 

 

 

 

Charlie Harrison

 

 

 

 

Company Secretary

 

 

 

Dated: May 05, 2017


INDEX TO EXHIBITS

 

 

 

Item

 

 

 

 

 

99.1

 

Change of Director’s Interest Notice, Donal O’Dwyer.

 

 

 

 

 

meso-ex991_68.htm

 

Exhibit 99.1

Appendix 3Y

Change of Director’s Interest Notice

 

 

 

Rule 3.19A.2

Appendix 3Y

 

Change of Director’s Interest Notice

 

Information or documents not available now must be given to ASX as soon as available.  Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

 

Name of entity Mesoblast Limited

ABN 68 109 431 870

 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.  

 

Name of Director

Donal O’Dwyer

Date of last notice

23 November 2015

 

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

 

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

Direct or indirect interest

Direct

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

 

-

 

Date of change

25 April 2017

No. of securities held prior to change

511,824 Options held as follows:

• 255,912 options held directly; and

• 255,912 options held indirectly.

 

619,818 Ordinary Shares held as follows:

• 300,000 shares held directly; and

• 319,818 shares held indirectly.

Class

Ordinary Shares

Number acquired

255,912

Number disposed

N/A

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

 

US$113,599

 

 

+ See chapter 19 for defined terms.

 

01/01/2011 Appendix 3Y Page 1

 

 


 

Appendix 3Y

Change of Director’s Interest Notice

 

 

 

No. of securities held after change

255,912 Options held as follows:

• 255,912 options held directly; and

• Nil options held indirectly.

 

875,730 Ordinary Shares held as follows:

• 555,912 shares held directly; and

• 319,818 shares held indirectly.

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Exercise of 255,912 options

 

Part 2 – Change of director’s interests in contracts

 

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

Detail of contract

N/A

Nature of interest

 

 

N/A

Name of registered holder

(if issued securities)

 

N/A

Date of change

N/A

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

 

N/A

Interest acquired

N/A

Interest disposed

N/A

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

 

N/A

Interest after change

N/A

 

Part 3 – +Closed period

 

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?

No

If so, was prior written clearance provided to allow the trade to proceed during this period?

N/A

 

 

+ See chapter 19 for defined terms.

 

01/01/2011 Appendix 3Y Page 2

 


 

Appendix 3Y

Change of Director’s Interest Notice

 

 

 

If prior written clearance was provided, on what date was this provided?

N/A

 

 

 

 

+ See chapter 19 for defined terms.

 

01/01/2011 Appendix 3Y Page 3